These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations. Galimberti F; Busch AM; Chinyengetere F; Ma T; Sekula D; Memoli VA; Dragnev KH; Liu F; Johnson KC; Guo Y; Freemantle SJ; Andrew AS; Greninger P; Robbins DJ; Settleman J; Benes C; Dmitrovsky E Int J Oncol; 2012 Nov; 41(5):1751-61. PubMed ID: 22923130 [TBL] [Abstract][Full Text] [Related]
6. Cyclopamine blocked the growth of colorectal cancer SW116 cells by modulating some target genes of Gli1 in vitro. Wu JY; Xu XF; Xu L; Niu PQ; Wang F; Hu GY; Wang XP; Guo CY Hepatogastroenterology; 2011; 58(110-111):1511-8. PubMed ID: 21940310 [TBL] [Abstract][Full Text] [Related]
7. LKB1 inhibits breast cancer partially through repressing the Hedgehog signaling pathway. Zhuang Z; Wang K; Cheng X; Qu X; Jiang B; Li Z; Luo J; Shao Z; Duan T PLoS One; 2013; 8(7):e67431. PubMed ID: 23861764 [TBL] [Abstract][Full Text] [Related]
8. Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation. Uhmann A; Niemann H; Lammering B; Henkel C; Hess I; Nitzki F; Fritsch A; Prüfer N; Rosenberger A; Dullin C; Schraepler A; Reifenberger J; Schweyer S; Pietsch T; Strutz F; Schulz-Schaeffer W; Hahn H Mol Cancer Ther; 2011 Nov; 10(11):2179-88. PubMed ID: 21878656 [TBL] [Abstract][Full Text] [Related]
9. Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer. Steg A; Amm HM; Novak Z; Frost AR; Johnson MR Cancer Biol Ther; 2010 Nov; 10(9):893-902. PubMed ID: 20814245 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy. Nitzki F; Tolosa EJ; Cuvelier N; Frommhold A; Salinas-Riester G; Johnsen SA; Fernandez-Zapico ME; Hahn H Oncotarget; 2015 Apr; 6(11):9113-24. PubMed ID: 25823816 [TBL] [Abstract][Full Text] [Related]
11. Detection of canonical hedgehog signaling in breast cancer by 131-iodine-labeled derivatives of the sonic hedgehog protein. Sims-Mourtada J; Yang D; Tworowska I; Larson R; Smith D; Tsao N; Opdenaker L; Mourtada F; Woodward W J Biomed Biotechnol; 2012; 2012():639562. PubMed ID: 22811598 [TBL] [Abstract][Full Text] [Related]
12. Hedgehog signaling pathway is inactive in colorectal cancer cell lines. Chatel G; Ganeff C; Boussif N; Delacroix L; Briquet A; Nolens G; Winkler R Int J Cancer; 2007 Dec; 121(12):2622-7. PubMed ID: 17683069 [TBL] [Abstract][Full Text] [Related]
13. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Taipale J; Chen JK; Cooper MK; Wang B; Mann RK; Milenkovic L; Scott MP; Beachy PA Nature; 2000 Aug; 406(6799):1005-9. PubMed ID: 10984056 [TBL] [Abstract][Full Text] [Related]
14. In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice. Sanchez P; Ruiz i Altaba A Mech Dev; 2005 Feb; 122(2):223-30. PubMed ID: 15652709 [TBL] [Abstract][Full Text] [Related]
15. Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line. Werminghaus P; Haase M; Hornsby PJ; Schinner S; Schott M; Malendowicz LK; Lammers BJ; Goretzki PE; Müller-Mattheis V; Markus Giessing ; Willenberg HS J Steroid Biochem Mol Biol; 2014 Jan; 139():7-15. PubMed ID: 24063979 [TBL] [Abstract][Full Text] [Related]
16. Hedgehog signal inhibitor forskolin suppresses cell proliferation and tumor growth of human rhabdomyosarcoma xenograft. Yamanaka H; Oue T; Uehara S; Fukuzawa M J Pediatr Surg; 2011 Feb; 46(2):320-5. PubMed ID: 21292081 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas. Tang JY; Xiao TZ; Oda Y; Chang KS; Shpall E; Wu A; So PL; Hebert J; Bikle D; Epstein EH Cancer Prev Res (Phila); 2011 May; 4(5):744-51. PubMed ID: 21436386 [TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice. Ecke I; Petry F; Rosenberger A; Tauber S; Mönkemeyer S; Hess I; Dullin C; Kimmina S; Pirngruber J; Johnsen SA; Uhmann A; Nitzki F; Wojnowski L; Schulz-Schaeffer W; Witt O; Hahn H Cancer Res; 2009 Feb; 69(3):887-95. PubMed ID: 19155313 [TBL] [Abstract][Full Text] [Related]
19. Effective targeting of Hedgehog signaling in a medulloblastoma model with PF-5274857, a potent and selective Smoothened antagonist that penetrates the blood-brain barrier. Rohner A; Spilker ME; Lam JL; Pascual B; Bartkowski D; Li QJ; Yang AH; Stevens G; Xu M; Wells PA; Planken S; Nair S; Sun S Mol Cancer Ther; 2012 Jan; 11(1):57-65. PubMed ID: 22084163 [TBL] [Abstract][Full Text] [Related]
20. A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists. Chenna V; Hu C; Pramanik D; Aftab BT; Karikari C; Campbell NR; Hong SM; Zhao M; Rudek MA; Khan SR; Rudin CM; Maitra A Mol Cancer Ther; 2012 Jan; 11(1):165-73. PubMed ID: 22027695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]